Whalerock Point Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Whalerock Point Partners’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,325	Closed	-$662K	–	161
2015 Q3	$662K	Hold	15,325	–	–	0.29%	69
2015 Q2	$647K	Sell	15,325 -350	-2%	-$14.8K	0.27%	70
2015 Q1	$607K	Hold	15,675	–	–	0.25%	74
2014 Q4	$527K	Sell	15,675 -400	-2%	-$14.1K	0.22%	78
2014 Q3	$562K	Sell	16,075 -1,500	-9%	-$51.4K	0.25%	73
2014 Q2	$577K	Buy	17,575 +600	+4%	+$20.5K	0.27%	72
2014 Q1	$625K	Hold	16,975	–	–	0.32%	59
2013 Q4	$651K	Buy	+16,975	New	+$536K	0.34%	54

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Whalerock Point Partners's WX Position: Q4 2015 in Review

Whalerock Point Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 15,325 shares — an estimated $662K sold.

Whalerock Point Partners first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $662K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Whalerock Point Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Whalerock Point Partners sold 15,325 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $662K.
Whalerock Point Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
Whalerock Point Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $662K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Whalerock Point Partners's 13F filing for Q4 2015, filed 10 Feb 2016.